StockData
Ensysce Biosciences, Inc. logo

Ensysce Biosciences, Inc. (ENSC) stock

ENSCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.38−0.03 (-6.28%)

Close on Nov 17, 2026Market cap $7.47MP/E –Yield –

Ensysce Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Ensysce Biosciences's price to book ratio was 0.5× on Apr 30, 2026, against 1.1× a year earlier. Over the last 3 years it ranged from 0.5× to 43.6×, with a median of 1.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20260.5×−1.9
2025Dec 31, 20252.4×+1.3
2024Dec 31, 20241.1×−1.0
2023Dec 29, 20232.0×−28.3
2021Oct 29, 202130.3×–

More Ensysce Biosciences figures

See a number that looks wrong?